Radionuclide Therapy Developers Attract Investor Attention in March China Fundraising

 
• By Dexter Jie Yan

China's Chengdu New Radiomedicine Technology and the radiotherapy CRDMO Mitro Biotech bagged a combined $94m in their respective new financing rounds during March. Meanwhile, Beijing Varnotech Biopharm secured $83m for its vaccine candidates for the prevention of herpes zoster and respiratory syncytial virus infections. 

funding
Chinese biotechs extended sizable deal-making into March • Source: Shutterstock

More from China

More from Focus On Asia